Clinical Skin Cancer is an international peer-reviewed, quarterly, journal dedicated to disseminating cutting-edge data to the practicing clinician by providing physicians and healthcare professionals with the most up-to-date, clinically relevant information available in order to enhance caregivers' ability to provide optimal care for their cancer patients. Clinical Skin Cancer publishes original articles describing various aspects of clinical and translational research of skin malignancies and is devoted to articles on detection, diagnosis, prevention, and treatment of skin malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches. Our mission is to be the premier source of clinically relevant information through promoting excellence in clinical research and facilitating the timely translation of that science to health care and clinical practice. Key objectives to achieve these goals include the nurturing and development of future generations of clinical scientists, and the dissemination of new knowledge related to skin malignancies.